Product Code: ETC13264406 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Nuclear Imaging Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 5.5 Billion by 2031, growing at a compound annual growth rate of 5.30% during the forecast period (2025-2031).
The Global Nuclear Imaging Market is a rapidly growing sector within the medical imaging industry, driven by advancements in technology, increasing prevalence of chronic diseases, and growing demand for early and accurate diagnosis. Nuclear imaging techniques, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), are widely used for diagnosing various conditions, including cancer, cardiovascular diseases, and neurological disorders. The market is also benefiting from the rising adoption of hybrid imaging systems that combine nuclear imaging with other modalities like CT and MRI for improved diagnostic accuracy. Key players in the global nuclear imaging market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, among others, who are investing in research and development to introduce innovative solutions and expand their market presence. The market is expected to continue its growth trajectory in the coming years, driven by increasing healthcare infrastructure development and the need for personalized medicine.
The Global Nuclear Imaging Market is experiencing growth due to technological advancements in imaging systems, increasing prevalence of chronic diseases like cancer and cardiovascular disorders, and rising demand for early and accurate diagnosis. The market is also benefiting from the expanding applications of nuclear imaging in neurology, cardiology, and oncology. Opportunities exist in the development of hybrid imaging modalities combining nuclear imaging with other diagnostic techniques, such as PET/CT and SPECT/CT, as well as the adoption of theranostics for personalized medicine. Additionally, the growing investments in research and development for novel radiopharmaceuticals and the increasing focus on molecular imaging are expected to drive further market expansion. However, challenges related to high costs, regulatory hurdles, and concerns about radiation exposure remain key considerations for market players.
The Global Nuclear Imaging Market faces several challenges, including regulatory hurdles and increasing concerns about radiation exposure. Strict regulations governing the use of radioactive materials in medical imaging procedures can hinder market growth. Additionally, the high cost of nuclear imaging equipment and procedures can limit adoption, particularly in emerging markets. Another significant challenge is the limited availability of technetium-99m, a widely used radioisotope in nuclear imaging, due to supply chain disruptions and geopolitical factors. Addressing these challenges will require technological advancements to reduce radiation doses, efforts to streamline regulatory processes, and investments in infrastructure to enhance access to nuclear imaging services worldwide.
The global nuclear imaging market is primarily driven by the increasing prevalence of cancer and cardiovascular diseases, which require accurate diagnosis and treatment monitoring. Technological advancements in imaging modalities, such as PET and SPECT scans, have enhanced the precision and efficiency of nuclear imaging procedures, further fueling market growth. Additionally, the rising geriatric population, who are more susceptible to chronic diseases, is contributing to the expanding demand for nuclear imaging services. Moreover, the growing awareness about early disease detection and the benefits of nuclear imaging in personalized medicine are driving the market forward. Regulatory approvals for new radiopharmaceuticals and imaging agents are also playing a crucial role in propelling the market expansion by offering improved diagnostic capabilities and treatment outcomes.
Government policies related to the Global Nuclear Imaging Market primarily focus on regulations, safety standards, and guidelines to ensure the proper use of nuclear imaging technology. These policies include licensing requirements for facilities using radioactive materials, protocols for radiation protection, and monitoring of radiation exposure levels. Additionally, governments may provide funding or incentives for research and development in the nuclear imaging sector to promote innovation and advancements in technology. Furthermore, regulatory bodies such as the Nuclear Regulatory Commission in the United States and the International Atomic Energy Agency at the international level play a crucial role in overseeing compliance with these policies to safeguard public health and the environment.
The Global Nuclear Imaging Market is expected to witness steady growth in the coming years, driven by increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, as well as advancements in imaging technologies. The market is likely to benefit from the rising adoption of nuclear imaging techniques for early and accurate disease diagnosis, treatment planning, and monitoring. Additionally, the growing investments in healthcare infrastructure in emerging markets and the expanding applications of nuclear imaging in neurology and oncology are anticipated to further propel market growth. However, challenges such as high costs associated with nuclear imaging procedures and the availability of alternative imaging modalities may hinder the market expansion to some extent. Overall, the Global Nuclear Imaging Market is poised for growth, with opportunities for innovation and market penetration in the forecast period.
The Global Nuclear Imaging Market is experiencing varied regional dynamics. Asia Pacific is expected to witness significant growth due to increasing healthcare infrastructure and rising awareness about early disease detection. North America holds a dominant position in the market, attributed to high healthcare expenditure and advanced technological developments. Europe is also a key market for nuclear imaging, driven by the presence of well-established healthcare systems and increasing adoption of nuclear medicine. The Middle East and Africa region is showing growing interest in nuclear imaging technologies, while Latin America is experiencing steady growth with improving healthcare facilities. Overall, the global nuclear imaging market is poised for growth across all regions, with each region contributing to the market`s expansion in unique ways.
Global Nuclear Imaging Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Nuclear Imaging Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Nuclear Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Global Nuclear Imaging Market - Industry Life Cycle |
3.4 Global Nuclear Imaging Market - Porter's Five Forces |
3.5 Global Nuclear Imaging Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Nuclear Imaging Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Nuclear Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Nuclear Imaging Market Revenues & Volume Share, By Portability, 2021 & 2031F |
3.9 Global Nuclear Imaging Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Global Nuclear Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Nuclear Imaging Market Trends |
6 Global Nuclear Imaging Market, 2021 - 2031 |
6.1 Global Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Nuclear Imaging Market, Revenues & Volume, By Single Photon-Emission Computed Tomography (SPECT), 2021 - 2031 |
6.1.3 Global Nuclear Imaging Market, Revenues & Volume, By Hybrid Pet, 2021 - 2031 |
6.1.4 Global Nuclear Imaging Market, Revenues & Volume, By Planar Scintigraphy, 2021 - 2031 |
6.2 Global Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Nuclear Imaging Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Nuclear Imaging Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.2.4 Global Nuclear Imaging Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.5 Global Nuclear Imaging Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Nuclear Imaging Market, Revenues & Volume, By Pocket-Sized/Handheld Device, 2021 - 2031 |
6.3.3 Global Nuclear Imaging Market, Revenues & Volume, By Fixed, 2021 - 2031 |
6.4 Global Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Nuclear Imaging Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Nuclear Imaging Market, Revenues & Volume, By Imaging Centers, 2021 - 2031 |
6.4.4 Global Nuclear Imaging Market, Revenues & Volume, By Academic and Research Centers, 2021 - 2031 |
6.4.5 Global Nuclear Imaging Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Nuclear Imaging Market, Overview & Analysis |
7.1 North America Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
7.2 North America Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
7.6 North America Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
8 Latin America (LATAM) Nuclear Imaging Market, Overview & Analysis |
8.1 Latin America (LATAM) Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
8.6 Latin America (LATAM) Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
9 Asia Nuclear Imaging Market, Overview & Analysis |
9.1 Asia Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
9.6 Asia Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
10 Africa Nuclear Imaging Market, Overview & Analysis |
10.1 Africa Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
10.6 Africa Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
11 Europe Nuclear Imaging Market, Overview & Analysis |
11.1 Europe Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
11.6 Europe Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
12 Middle East Nuclear Imaging Market, Overview & Analysis |
12.1 Middle East Nuclear Imaging Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Nuclear Imaging Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Nuclear Imaging Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Nuclear Imaging Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Nuclear Imaging Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Nuclear Imaging Market, Revenues & Volume, By Portability, 2021 - 2031 |
12.6 Middle East Nuclear Imaging Market, Revenues & Volume, By End user, 2021 - 2031 |
13 Global Nuclear Imaging Market Key Performance Indicators |
14 Global Nuclear Imaging Market - Export/Import By Countries Assessment |
15 Global Nuclear Imaging Market - Opportunity Assessment |
15.1 Global Nuclear Imaging Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Nuclear Imaging Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Nuclear Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Nuclear Imaging Market Opportunity Assessment, By Portability, 2021 & 2031F |
15.5 Global Nuclear Imaging Market Opportunity Assessment, By End user, 2021 & 2031F |
16 Global Nuclear Imaging Market - Competitive Landscape |
16.1 Global Nuclear Imaging Market Revenue Share, By Companies, 2024 |
16.2 Global Nuclear Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |